A Non-Hallucinogenic LSD Analog With Therapeutic Potential for Mood Disorders

被引：0
|
作者：
Valles, Argel Aguilar [1 ]
Lewis, Vern [1 ]
Telfer, Andre [1 ]
Arsenault, Emily [1 ]
Taghavi-Abkuh, Fatimeh-Frouh [1 ]
El Sayegh, Fatema [1 ]
Abizaid, Alfonso [1 ]
机构：
[1] Carleton Univ, Ottawa, ON, Canada
来源：
NEUROPSYCHOPHARMACOLOGY | 2022年 / 47卷
关键词：
LSD; Dendritic Arborization; Spine Morphogenesis; Stress Coping; 5-HT2A Receptor;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P358
引用
收藏
页码：269 / 270
页数：2
相关论文
共 50 条
  • [41] Therapeutic implications for NMDA receptors in mood disorders
    Hashimoto, Kenji
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (07) : 735 - 737
  • [42] LSD1 IS A POTENTIAL THERAPEUTIC TARGET IN MEDULLOBLASTOMA
    Schulte, Johannes
    Pajtler, Kristian
    Buettner, Reinhard
    Kirfel, Jutta
    Thor, Theresa
    Schramm, Alexander
    Eggert, Angelika
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 826 - 826
  • [43] Therapeutic Utilisations of Vasopressin and Oxytocin in Mood Disorders
    Scantamburlo, Gabrielle
    Pitchot, William
    Pinto, Emmanuel
    Ansseau, Marc
    Legros, Jean-Jacques
    RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY, 2007, 1 (02) : 157 - 161
  • [44] Sirukumab: A Potential Treatment for Mood Disorders?
    Zhou, Aileen J.
    Lee, Yena
    Salvadore, Giacomo
    Hsu, Benjamin
    Fonseka, Trehani M.
    Kennedy, Sidney H.
    McIntyre, Roger S.
    ADVANCES IN THERAPY, 2017, 34 (01) : 78 - 90
  • [45] Sirukumab: A Potential Treatment for Mood Disorders?
    Aileen J. Zhou
    Yena Lee
    Giacomo Salvadore
    Benjamin Hsu
    Trehani M. Fonseka
    Sidney H. Kennedy
    Roger S. McIntyre
    Advances in Therapy, 2017, 34 : 78 - 90
  • [46] Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants
    Duan, Wenwen
    Cao, Dongmei
    Wang, Sheng
    Cheng, Jianjun
    CHEMICAL REVIEWS, 2023, 124 (01) : 124 - 163
  • [47] Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential
    Botsford, Sabrina L.
    Yang, Sharon
    George, Tony P.
    AMERICAN JOURNAL ON ADDICTIONS, 2020, 29 (01): : 9 - 26
  • [48] The use of visual analog scales in mood disorders: A critical review
    Ahearn, EP
    JOURNAL OF PSYCHIATRIC RESEARCH, 1997, 31 (05) : 569 - 579
  • [49] GM-2040 is a Novel Putative Non-Hallucinogenic 5HT2A Agonist With Attenuated Head Twitch and Retained Antidepressant Activity
    Klein, Adam
    Austin, Eric
    Dvorak, Dino
    Marek, Gerard
    Sporn, Jonathan
    Kiss, Laszlo
    Hughes, Zoe
    Kruegel, Andrew
    BIOLOGICAL PSYCHIATRY, 2023, 93 (09) : S307 - S307
  • [50] Future therapeutic targets in mood disorders: the glucocorticoid receptor
    McQuade, R
    Young, AH
    BRITISH JOURNAL OF PSYCHIATRY, 2000, 177 : 390 - 395
12345